Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Building the Next Generation of Leaders in Life Sciences – Lessons from a QA Perspective

As the founder of BHMP Network, Abiola Mariah will explore how inclusive and adaptive leadership practices, informed by QA principles, can strengthen regulatory compliance, foster innovation, and drive equitable outcomes.

The agenda will cover the evolving landscape of life sciences, key leadership challenges, core and essential skills such as emotional intelligence, collaboration, continuous learning, and accountability, all supported by real-world case studies to provide practical strategies for leadership development.

Cost: £10

Essential GCP Record Retention

In this session, Arkivum team members Rob Buckton and Tom Lynam will explore everything you need to know about retaining essential GCP records and data. This includes:
- Why retention matters, expanding on key retention regulations (EU CTR, MHRA updates and more).
- What good looks like taking into account ICH E6(R3) and ALCOA+.
- How to move towards good and why digital safeguarding and preservation are both crucial.
- How to implement a risk based approach to retention.
- Why data sprawl is a challenge and how consolidation supports compliance.

IP and Commercialisation Strategies in the Life Sciences Sector

This session is presented by Lauren MIlls and Joeeta Murphy from iP21 and will explore how IP can be strategically leveraged to drive innovation and commercial success in the Life Sciences sector. From patents protecting cutting-edge biotechnologies and pharmaceuticals to trade marks and design rights supporting brand identity and product differentiation, we’ll examine the key IP tools available to researchers, startups, and established companies. The talk will also cover common pitfalls, ownership issues, collaboration agreements, and the role of software and data in life sciences.

PrecisionLife & Ovation partner to develop first precision medicine test to inform reimbursement of GLP-1 anti-obesity drugs

Collaboration to support value-based reimbursement models for GLP-1 receptor agonists, optimizing patient outcomes, increasing markets, and healthcare sustainability

OXFORD, UK and PORTLAND, ME – 25 November 2025 – Ovation.io, a leading human omics and clinical data company, and PrecisionLife, a precision medicine company transforming how complex chronic diseases are understood and managed, today announced a collab

Scientist/Senior Scientist – Therapeutics Discovery

Who we are:   

Life, Reimagined    

Constructive Bio is a VC-backed biotechnology startup based in Whittlesford, Cambridge. Our unique technology turns living cells into biofactories, creating sustainable new materials and therapeutics. With full control of the genetic sequence and code, we are exploring chemical space previously unreached by natural biology.  

Biocair France Relocates to Strategic New Facility at Paris-Charles de Gaulle Airport

24 November 2025, Paris, France / Biocair, an established global leader in life science logistics, today announced the relocation of its Paris facility to a new, substantially larger premises strategically positioned within the Paris-Charles de Gaulle airport cargo zone. This move strengthens Biocair’s presence in the geographical and logistical center of one of Europe’s major transport hubs.

Macomics Announces Updated Data of the ENIGMAC Drug Discovery Platform and The Role of Macrophages in Fibrotic Disease

Edinburgh and Cambridge, UK, 25 November 2025 - Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in macrophage mediated antifibrotic therapy.

Macomics’ ENIGMAC drug discovery platform is designed to discover therapeutic targets and unlock disease specific target biology. The platform enables identification and validation of novel targets and provides a translationally relevant path to the clinic through the development of more physiologically relevant human models combined with proprietary gene editing technology.

Scientist, Automation & Technical Facilities

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

Creative Biolabs' Integrated Discovery Platforms to Confront Complex Antibody Research

Creative Biolabs is rewriting the methods scientists use to develop binders and antibodies in the changing environment of therapeutic discovery. The company, which has a set of advanced platforms, is, therefore, a partner that many researchers can hardly do without as they go deeper into the most challenging molecular‍ ‌‌frontiers.

Subscribe to